identified a novel immunosuppressive molecule, the T-cell immune receptor (TIGIT), which is highly expressed on CD20+ B cells and is linked to poorer OS and disease-free survival (DFS) in patients with gastric cancer by influencing CD8+ T-cell depletion (12). The gene discussed is CD8A; the disease is gastric cancer.